Merck and Japan's Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy ...

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

A CANCER that creeps up quietly, spotted when it’s too late – 60 per cent of patients will die within a year of their ...

After a progression-free survival win last year raised hopes for the combo's potential in hepatocellular carcinoma, an overall survival miss brings the study to a close.

A new study has found that it is older age hat is most strongly linked to poorer survival outcomes in liver cancer.

Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...

October marks Liver Cancer Awareness Month, an initiative that brings attention to the disease identified by NIH as the third ...

The risk of dying from the most common form of primary liver cancer is about 30 percent higher for patients with low household income compared to those with middle or high household income, according ...